Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. (Q42627143)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Richard Katholi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Paul A Sobotka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Michael Böhm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Felix Mahfoud

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Richard Katholi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Murray D Esler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Henry Krum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

7 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

9917

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

622-629

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

Selected major risk factors and global and regional burden of disease

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Resistant hypertension: an overview of evaluation and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Sympatho-renal axis in chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Renal sympathetic-nerve ablation for uncontrolled hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Percutaneous renal denervation: new treatment option for resistant hypertension and more?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

ESH position paper: renal denervation - an interventional therapy of resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Renal artery stenosis after renal sympathetic denervation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Treatment of stage I hypertension and development of renal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Renal denervation in moderate to severe CKD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Detection and treatment of resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Effect of spironolactone on blood pressure in subjects with resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Updated ESH position paper on interventional therapy of resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Splanchnicectomy for essential hypertension; results in 1,266 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Surgical therapy for persistent hypertension after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Blood pressure regulation in end-stage renal disease and anephric man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Vascular and renal hemodynamic changes after renal denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

Does renal artery supply indicate treatment success of renal denervation?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962192-3

7 January 2021

10.1016/S0140-6736(13)62192-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210779%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference